Table 3. Association between AHNAK2 expression and the clinicpathological features of PDAC.
Characteristics | Number | AHNAK2 expression | P value | |
---|---|---|---|---|
High (n=48) | Low (n=31) | |||
Age (years) | ||||
<65 | 49 | 31 | 18 | 0.56 |
≥65 | 30 | 17 | 13 | |
Gender | ||||
Male | 47 | 25 | 22 | 0.10 |
Female | 32 | 23 | 9 | |
Pathology grade | ||||
I-II | 57 | 35 | 22 | 0.85 |
above II | 22 | 13 | 9 | |
Vessel/nerve invasion | ||||
Yes | 36 | 21 | 15 | 0.69 |
No | 43 | 27 | 16 | |
Tumor invasion depth | ||||
T1, T2 | 63 | 41 | 22 | 0.12 |
T3, T4 | 16 | 7 | 9 | |
Lymph node metastasis | ||||
N0 | 47 | 26 | 21 | 0.56 |
N1 | 32 | 22 | 10 | |
Distant metastasis | ||||
M0 | 78 | 47 | 31 | >0.99 |
M1 | 1 | 1 | 0 | |
AJCC-stage | ||||
I-II | 36 | 21 | 15 | 0.69 |
above II | 43 | 27 | 16 | |
Family history | ||||
Yes | 0 | 0 | 0 | >0.99 |
No | 79 | 48 | 31 | |
Smoking history | ||||
Yes | 18 | 10 | 8 | 0.61 |
No | 61 | 38 | 23 | |
Drinking history | ||||
Yes | 18 | 11 | 7 | 0.97 |
No | 61 | 37 | 24 | |
Type II diabetes | ||||
Yes | 13 | 8 | 5 | 0.95 |
No | 66 | 40 | 26 |
P<0.05 was considered as statistically significant.